Skip to main content
. 2018 May 3;28(10):4296–4305. doi: 10.1007/s00330-018-5439-6

Table 1.

Patient and tumour-related characteristics

Characteristics n (%)
Sex
 Male 36 (90.0)
 Female 4 (10.0)
Age (mean ± SD) 68.4 ± 8.5
Location (total)
 Cervical 5
 Proximal third 11
 Middle third 26
 Distal third 13
 Gastro-oesophageal junction 4
cT
 cT3 27 (67.5)
 cT4 13 (32.5)
Dose (Gy)
 54 1 (2.5)
 59.6 2 (5.0)
 60 34 (85.0)
 61.2 1 (2.5)
 62.4 1 (2.5)
 64 1 (2.5)
Chemotherapy
 Cisplatin/5-FU 29 (72.5)
 Nedaplatin/5-FU 9 (22.5)
 Docetaxel/cisplatin/5-FU 2 (5.0)

5-FU 5-fluorouracil